Support comprehensive treatment for pain and substance use disorders
Heading

Share Your Story
The AMA wants to hear directly from physicians how they are responding to the nation’s opioid epidemic. By sharing your story, you will help inform AMA advocacy in our work on behalf of physicians and patients.
Heading
Fulfill your state-mandated CME credits while enhancing your knowledge of opioid and non-opioid pain management, safe opioid prescribing and substance use treatment. Learn now.
Substance Abuse and Mental Health Services Administration (SAMHSA)
Buscar Tratamiento De Calidad Para Trastornos De Uso De Sustancias
Given the complex needs of pregnant and postpartum women and their children, and the number of systems they encounter during critically important periods in their lives, ASAM provides policy recommendations on substance use, misuse, and SUDs during and following pregnancy.
JAMA Psychiatry
AMA Journal of Ethics. September 2017, Volume 19, Number 9: 922-930.
Sarah E. Wakeman, MD
PCSS-MAT is comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder, including courses satisfying the DATA-2000 waiver.
Access 8 hrs of training required for a DEA waiver to prescribe buprenorphine in-office to patients with a substance use disorder.